Data gathered: March 6
AI Stock Analysis - Penumbra (PEN)
Analysis generated February 10, 2024. Powered by Chat GPT.
Penumbra is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices. The company is specialized in products that address challenging medical conditions in markets such as neuro and peripheral vascular conditions. Penumbra's commitment to improving patient outcomes through cutting-edge technology has positioned it as a leader in its respective fields, fostering a reputation for innovation and quality.
Stock Alerts - Penumbra (PEN)
 |
Penumbra | March 6 Insider Alert: Shiu Lambert is selling shares |
|
Penumbra | February 26 Business Outlook among employees is up by 4.2% over the last month. |
|
Penumbra | February 25 AI Score is up by 24.1% in the last couple of days. |
|
Penumbra | February 21 AI Score is up by 28.2% in the last couple of days. |
Alternative Data for Penumbra
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 52 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 30,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | 78 | Sign up | Sign up | Sign up |
| Patents | 62 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,692 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 938 | Sign up | Sign up | Sign up |
| Twitter Followers | 4,126 | Sign up | Sign up | Sign up |
| Twitter Mentions | 61 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 3,870 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 50 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,685 | Sign up | Sign up | Sign up |
About Penumbra
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally.
| Price | $286.38 |
| Target Price | Sign up |
| Volume | 392,650 |
| Market Cap | $10.9B |
| Year Range | $163.64 - $303.76 |
| Dividend Yield | 0% |
| PE Ratio | 766.54 |
| Analyst Rating | 75% buy |
| Industry | Medical Devices |
In the news
 |
Bank of New York Mellon Corp Purchases 1,823 Shares of Penumbra, Inc. (NYSE:PEN)March 4 - ETF Daily News |
Penumbra (PEN) Price Target Increased by 16.16% to 315.31March 3 - Fintel |
|
|
Financial Comparison: Penumbra (NYSE:PEN) and Intelligent Bio Solutions (NASDAQ:INBS)March 3 - ETF Daily News |
|
Comparing Autonomix Medical (NASDAQ:AMIX) & Penumbra (NYSE:PEN)March 1 - ETF Daily News |
|
Blue Trust Inc. Sells 268 Shares of Penumbra, Inc. (NYSE:PEN)February 26 - ETF Daily News |
|
Penumbra (PEN) Expected to Announce Earnings on ThursdayFebruary 25 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 301M | 101M | 200M | 30M | 36M | 0.850 |
| Q2 '24 | 299M | 77M | -77M | -60M | -70M | 0.640 |
| Q1 '24 | 279M | 98M | 181M | 11M | 18M | 0.410 |
| Q4 '23 | 285M | 98M | 187M | 54M | 41M | 0.760 |
| Q3 '23 | 271M | 93M | 178M | 9.2M | 15M | 0.670 |
Insider Transactions View All
| Shiu Lambert filed to sell 32,969 shares at $282.9. March 5 '25 |
| Shiu Lambert filed to sell 24,270 shares at $289.8. March 5 '25 |
| O'Rourke Bridget filed to sell 5,573 shares at $285.5. March 5 '25 |
| Roberts Johanna filed to sell 66,587 shares at $290.4. March 5 '25 |
| Roberts Johanna filed to sell 66,539 shares at $291.4. March 5 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$104.71 0% | 65 |
 |
Edwards LifesciencesEW |
$72.85 0% | 32 |
 |
Intuitive SurgicalISRG |
$568.02 0% | 60 |
 |
MedtronicMDT |
$94.06 0% | 45 |
 |
StrykerSYK |
$395.69 0% | 59 |
Read more about Penumbra (PEN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Penumbra?
The Market Cap of Penumbra is $10.9B.
What is Penumbra's PE Ratio?
As of today, Penumbra's PE (Price to Earnings) ratio is 766.54.
What is the current stock price of Penumbra?
Currently, the price of one share of Penumbra stock is $286.38.
How can I analyze the PEN stock price chart for investment decisions?
The PEN stock price chart above provides a comprehensive visual representation of Penumbra's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Penumbra shares. Our platform offers an up-to-date PEN stock price chart, along with technical data analysis and alternative data insights.
Does PEN offer dividends to its shareholders?
As of our latest update, Penumbra (PEN) does not offer dividends to its shareholders. Investors interested in Penumbra should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Penumbra?
Some of the similar stocks of Penumbra are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.